<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="cti21107-fig-0003" orientation="portrait" position="float">
 <label>Figure 3</label>
 <caption>
  <p>Elevated CD4
   <sup>+</sup> Tfh and GC B cells by increased expression of SHM and CSR genes lead to early IgG class switch for A‐eIIV. Vaccine responses were assessed by FACS 
   <bold>(a)</bold> for CD4
   <sup>+</sup> Tfh cells 
   <bold>(b)</bold> and GC B cells 
   <bold>(c)</bold> at days 7 and 21 post‐vaccination in the iLN. Expression of AID, Bcl6, IRF4, Pax5 and c‐Myc in B cells from iLN (relative expression to GAPDH expression, expressed in 
   <math id="nlm-math-1">
    <msup>
     <mn>2</mn>
     <mrow>
      <mi mathvariant="normal">Δ</mi>
      <msub>
       <mi>C</mi>
       <mi mathvariant="normal">t</mi>
      </msub>
     </mrow>
    </msup>
   </math>) at day 7 post‐vaccination 
   <bold>(d)</bold>. Quantity 
   <bold>(f)</bold> and proportion 
   <bold>(g)</bold> of H3N2‐1968 HA‐specific IgM and IgG at days 7 and 21 post‐vaccination, measured by ELISA AUC endpoint titres (Supplementary figure 
   <xref rid="cti21107-sup-0001" ref-type="supplementary-material">2</xref>). Data represent the mean, SEM and individual responses, 
   <italic>n</italic> = 4 or 5 mice per group. *shows statistical significance by one‐way ANOVA (mixed model) for eIIV versus S‐IIV, *
   <italic>P</italic> &lt; 0.05, **
   <italic>P</italic> &lt; 0.01 and ***
   <italic>P</italic> &lt; 0.005, experiments were repeated twice. Representative FACS plots were gated on lymphocytes for FSC/SSC and live/dead 
   <bold>(a)</bold>.
  </p>
 </caption>
 <graphic id="nlm-graphic-7" xlink:href="CTI2-9-e1107-g003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
